Share
Market Research Report

DEPRESSION THERAPEUTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Drug Type [AntidepressantsSelective Serotonin Reuptake Inhibitors (SSRIs) · Selective Norepinephrine Reuptake Inhibitors (SNRIs) · Serotonin Modulators · Tricyclic & Tetracyclic Antidepressants · and Atypical Antidepressants
  • By IndicationMajor Depressive Disorder (MDD) · Bipolar Disorder · Dysthymic Disorder · Postpartum Depression · Seasonal Affective Disorder (SAD) · Premenstrual Dysphoric Disorder (PMDD) · Others
  • By Distribution ChannelHospital Pharmacies · Retail Pharmacies · Online Pharmacies
  • Published In28 Apr 2026
  • Report CodeCMI1307
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Drug Type
      • Market Snippet, By Indication
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Recent Drug Launches
    • Epidemiology
    • Pipeline Analysis
    • Distribution Landscape
    • Merger, Acquisition, and Collaborations
    • Regulatory Scenario
    • Key Developments
    • PEST Analysis
  4. Global Depression Therapeutics Market

    , By Drug Type, 2021 – 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Antidepressants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
        • Selective Serotonin Reuptake Inhibitors (SSRIs)
        • Selective Norepinephrine Reuptake Inhibitors (SNRIs)
        • Serotonin Modulators
        • Tricyclic & Tetracyclic Antidepressants
        • Atypical Antidepressants
    • Antipsychotics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
  5. Global Depression Therapeutics Market

    , By Indication, 2021 – 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Major Depressive Disorder (MDD)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
    • Bipolar Disorder
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
    • Dysthymic Disorder
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
    • Postpartum Depression
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
    • Seasonal Affective Disorder (SAD)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
    • Premenstrual Dysphoric Disorder (PMDD)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
  6. Global Depression Therapeutics Market

    , By Distribution Channel, 2021 – 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
  7. Global Depression Therapeutics Market

    , By Region, 2021 – 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Drug Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Indication, 2021 –2033, (US$ Bn)
      • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021–2033, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Bn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Drug Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Indication, 2021 –2033, (US$ Bn)
      • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021–2033, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Drug Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Indication, 2021 –2033, (US$ Bn)
      • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021–2033, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Drug Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Indication, 2021 –2033, (US$ Bn)
      • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021–2033, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Drug Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Indication, 2021 –2033, (US$ Bn)
      • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021–2033, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Drug Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Indication, 2021 –2033, (US$ Bn)
      • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021–2033, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/ Region,  2021 –2033, (US$ Bn)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape

    • Company Profiles
      • Johnson & Johnson
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • GlaxoSmithKline plc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Otsuka Pharmaceutical Co., Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Takeda Pharmaceutical Company Limited.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Eli Lilly and Company
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Sanofi S.A.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Pfizer, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Allergan plc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • H. Lundbeck A/S
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Alkermes
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Allergan
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Novartis AG
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Biogen
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Sage Therapeutics, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • AbbVie Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
  9. Section

    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 36 market data tables and 26 figures on “Global Depression Therapeutics Market” – Global forecast to 2033